Endovascular stents for renal artery revascularization

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 6, 1998, Pages 695-701

  Tuttle, Katherine R ^a   Raabe, Rodney D ^b  

^a Heart Institute of Spokane   (United States)

^b SACRED HEART MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; ENDOVASCULAR SURGERY; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORTALITY; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; STENT; SURGICAL TECHNIQUE;

AGED; HUMANS; MIDDLE AGED; RENAL ARTERY OBSTRUCTION; STENTS; TREATMENT OUTCOME;

EID: 0031770609     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199811000-00013     Document Type: Review

References (49)

1. Greco BA, Breyer JA. Atherosclerotic ischemic renal disease. Am J Kidney Dis 1997; 29:176-187.
2. Steinbach F, Novick AC, Campbell S, Dkstra D. Long-term survival after surgical revascularization for atherosclerotic renal artery disease. J Urol 1997; 158:38-41. This study analysed the long-term clinical outcome and survival after surgical revascularization for atherosclerotic RAS. A creatinine level of 3 mg/dl or less predicted favorable outcomes for blood pressure and renal function. Bilateral RAS also predicted a favorable renal function result.
3. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984; 11:383-392.
4. Standness DE. Natural history of renal artery stenosis. Am J Kidney Dis 1994; 24:630-635.
5. Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998; 53:735-742. This is a natural history study which reaffirms that atherosclerotic RAS is progressive. Stenosis of 60% or greater was associated with a 2-year atrophy rate of 21%. Atrophy correlated with declining renal function.
6. Davidson R, Wilcox CS. Diagnostic usefulness of renal scanning after angiotensin converting enzyme inhibitors. Hypertension 1991; 18:299-303.
7. Miralles M, Covas MI, Martinez-Miralles E, Cairols M, Cotillas J, Santiso MA. Captopril test and renal duplex scanning for the primary screening of renovascular disease. Am J Hypertens 1997; 10:1290-1296. Renal duplex scanning was combined with captopril-stimulated plasma renin activity measurement and showed relatively high sensitivity, specificity, and positive predictive value for renovascular hypertension.
8. Oliva VL, Soulez G, Lesage D, Nicolet V, Roy MC, Courteau M, et al. Detection of renal artery stenosis with Doppler sonography before and after administration of captopril: value of early systolic rise. Am J Roentgen 1998; 170:169-175. Administration of captopril improves the detection of RAS by a change in waveform pattern with Doppler ultrasonography.
9. Prince MR, Schoenberg SO, Ward JS, Londy FJ, Wakefield TW, Stanley JC. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology 1997; 205:128-136.
10. Wasser MN, Westenberg J, van der Hulst VP, van Baalen J, van Bockel JH, van Erkel AR, Pattyname PM. Hemodynamic significance of renal artery stenosis: digital subtraction angiography versus systolically gated three-dimensional phase-contrast MR angiography. Radiology 1997; 202:333-338.
11. Berkman J, Rifkin H. Unilateral nodular diabetic glomerulosclerosis. Metabolism 1973; 22:715-722.
12. Hansen KJ, Starr SM, Sand RE, Burkhart JM, Plonk GW, Dean RH. Contemporary surgical management of renovascular disease. J Vasc Surg 1992; 16:319-331.
13. Weibull H, Bergqvist D, Bergentz S-E, Jonsson K, Hulthén L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993; 18:841-852.
14. Cambria RP, Brewster DC, L'Italien GJ, Gertler JP, Abbott WM, LaMuraglia GM, et al. Renal artery reconstruction tor the preservation of renal function. J Vasc Surg 1996; 24:371-382.
15. Hallett JW, Fowl R, O'Brien PC, Bernatz PE, Pairolero PC. Cherry KJ, Hollier LH. Renovascular operations in patients with chronic renal insufficiency: do the benefits justify the risks? J Vasc Surg 1987; 5:622-627.
16. Dean RH, Tribble RW, Hansen KJ, O'Neil E, Craven TE, Redding JF. Evolution of renal insufficiency in ischemic nephropathy. Ann Surg 1991; 213:446-456.
17. Reilly JM, Rubin BG, Thompson RW, Allen BT, Flye MW, Anderson CB, Sicard GA. Revascularization of the solitary kidney: a challenging problem in a high risk population. Surgery 1996; 120:732-737.
18. Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309:274-279.
19. Canzanello VJ, Millan VG, Spiegel JE, Ponce SP, Kopelman RI, Madias NE. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertension 1989; 13:163-172.
20. Martin LG, Cork RD, Kaufman SL. Long-term results of angioplasty in 110 patients with renal artery stenosis. J Vasc Interv Radiol 1992; 3:619-626.
21. Eldrup-Jorgensen J, Harvey HR, Sampson LN, Amberson SM, Bredenberg CE. Should percutaneous transluminal renal angioplasty be applied to ostial renal artery atherosclerosis? J Vasc Surg 1995; 21:909-915.
22. Baert AL, Wilms AA, Vermylen J, Suy R. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc Interven Radiol 1990; 13:22-28.
23. Plouin P-F, Darné B, Chatellier G, Pannier I, Battaglia C, Raynaud A, Azizi M. Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension 1993; 21:89-96.
24. Jensen G, Zachrisson B-F, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995; 48:1936-1945.
25. Hovinga TKK, deJong PE, de Zeeuw D, Donker AJM, Shuur KH, van der Hem GK. Restenosis prevalence and long-term effects on renal function after percutaneous transluminal renal angioplasty. Nephron 1986; 44:64-67.
26. Tuttle KR, Chouinard RF, Webber JT, Dahlstrom LR, Short RA, Henneberry KJ, et al. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent. Am J Kidney Dis 1998; 32:611-622. This is a prospective study of 148 arteries treated by the endovascular stent for atherosclerotic, ostial RAS that had failed PTRA. The stent was highly successful (98%), and had low rates of re-stenosis and complications. Control of hypertension improved in the majority of cases, and renal function stabilized even in those with advanced renal failure. Four of eight dialysis-dependent patients recovered renal function.
27. Hennequin LM, Joffre FG, Rousseau HP, Aziza R, Tregant P, Bernadet P, et al. Renal artery stent placement: long-term results with the Wallstent endoprosthesis. Radiology 1994; 191:713-710.
28. van de Ven PJG, Beutler JJ, Kaatee R, Beek FJA, Mali WP Th M, Geyskes GG, Koomans HA. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995; 346:672-674.
29. MacLeod M, Taylor AD, Baxter G, Harden P, Briggs D, Moss J, et al. Renal artery stenosis managed by Palmaz stent insertion: technical and clinical outcome. J Hypertens 1995; 13:1791-1795.
30. Dorros G, Jaff M, Jain A, Dufek C, Mathiak L. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 1995; 75:1051-1055.
31. Henry M, Amor M, Henry I, Ethevenot G, Allaoui M, Tricoche O, et al. Stent placement in the renal artery: three year experience with the Palmaz stent. J Vasc Interv Radiol 1996; 7:343-350.
32. Blum V, Krumme B, Flügel P, Gabelmann A, Lehnert T, Buitrago-Tellez C, et al. Treatment of ostial renal artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997, 336:456-465.
33. Harden PN, MacLeod MJ, Rodger RSC, Baxter GM, Connell JMC, Dominiczak AF, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349:1133-1136. This is the first publication to document a decrease in the rate of loss of renal function after renal artery revascularization by the endovascular stent. Some patients with unilateral disease or who were dialysis-dependent had a beneficial renal function response.
34. 2 and gadopentetate dimeglumine were successfully used for renal artery stent placement in a patient at high risk to receive iodinated contrast.
35. Rees CR, Palmaz JC, Becker GJ, Ehrman K, Richter GM, Noeldge G, et al. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology 1991; 181:507-514.
36. Kuhn F-P, Kutkuhn B, Torsello G, Modder V. Renal artery stenosis: preliminary results of treatment with the Strecker stent. Radiology 1991; 180:367-372.
37. Wilms GE, Peene PT, Vaert AL, Nevelsteen AA, Suy RM, Verhaeghe RH, et al. Renal artery stent placement with use of the Wallstent endoprosthesis. Radiology 1991; 179:457-462.
38. McLaughlin K. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349:1839-1840.
39. Boero R, Rabbia C, Saviod, Quarello F, Piccoli G. Effect of reneal-artery stenting of progression of renovascular renal failure Lancet 1997; 349:1841. The rate of loss of renal function was decreased in this small group of patients (n = 12) after renal artery stenting.
40. Mikhail A, Cook GJR, Reidy J, Scoble JE. Progressive renal dysfunction despite successful renal artery angioplasty in a single kidney. Lancet 1997; 349:926. Renal function may deteriorate in some cases after successful interventional revascularization (PTRA in this study). Suspected causes include atheroemboli and progression of parenchymal disease.
41. Khosla S, White CJ, Collins TJ, Jenkins JS, Shaw D, Ramee SR. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure. Am J Cardiol 1997; 80:362-366. Patients (n = 48) with unstable angina or congestive heart failure had an improvement in cardiac status after renal artery revascularization by the stent. Benefit of renal artery stenting was seen even in those who also had coronary revascularization.
42. Weatherford DA, Freeman MB, Regester RF, Serrell PF, Steven SL, Goldman MH. Surgical management of flash pulmonary edema secondary to renovascular hypertension. Am J Surg 1997; 174:161-163. Surgical revascularization attenuated recurrent episodes of flash pulmonary edema in patients with RAS who had failed medical management.
43. Ducloux M, Jamali M, Chalopin M. Chronic congestive heart failure associated with bilateral renal artery stenosis. Clin Nephrol 1997; 48:54-55. This is a case report of a patient with chronic congestive heart failure who had an improvement in New York Heart Association class from IV to I after renal artery revascularization.
44. Nicita G, Villari D, Marzocco M, Marzi VL, Trippitelli A, Santoro G. Endoluminal stent placement after percutaneous transluminal angioplasty in the treatment of post-transplant renal artery stenosis. J Urol 1998; 159:34-37. Allograft RAS may recur after PTRA. In a series of seven patients, endovascular stent placement succeeded after repeated PTRA failures.
45. Miller GA, Ford KK, Braun SD, Newman GE, Moore AV Jr, Malone R, Dunnick NR. Percutaneous transluminal angioplasty vs. surgery for renovascular hypertension. Am J Roentgen 1985; 144:447-450.
46. von Knorring J, Edgren J, Lepantalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiol 1996; 37:36-40.
47. Klinge J, Mali WPTM, Puijlaert CBAJ, Geyskes GG, Becking WB, Feldberg MAM. Percutaneous transluminal renal angioplasty: initial and long-term results. Radiology 1989; 171:501-506.
48. Beek FJA, Kaatee R, Beutler JJ, van der Ben PJ, Mali WPTM. Complications during renal artery stent placement for atherosclerotic ostial stenosis. Cardiovasc Interven Radiol 1997; 20:184-190. Complication rates for placement of endovascular stents into renal arteries have declined with increased experience. This relates to greater operator expertise, better patient selection, and improved devices.
49. Baboolal K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998; 31:971-973. The mortality rate of patients with bilateral RAS managed medically was high: 38% at 2 years. All were cardiovascular in nature. Rates of end-stage renal disease were 12% (crude) and 30% (adjusted for mortality) at 5 years. These rates appear higher than those reported for patients who undergo revascularization procedures. However, the actual impact on mortality and other major endpoints (end-stage renal disease and cardiovascular events) will be determined by prospective trials that compare treatment modalities.